EMA Adopts Positive Opinion of RLS Treatment Targin

European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Targin. By Mundipharma, Targin is a fixed combination of prolonged-release oxycodone/naloxone, and is a second-line symptomatic treatment of patients with severe to very severe idiopathic restless legs syndrome (RLS), after failure of dopaminergic therapy.

Dental Sleep Solutions Partners with GoGo Billing

Dental Sleep Solutions, which offers end-to-end implementation solutions for dental practices via its flagship product DS3 Software, has entered a partnership with GoGo Billing, which manages billing services for DSM, TMD, and other medically necessary dental treatments.

Philips Unveils “The Answer” at Medtrade Fall 2014

Philips Respironics showcased “The ANSWER,” a comprehensive business transformation process that connects product, technology, and workflow innovations for both sleep and respiratory care management, at Medtrade Fall.

Reading a Biological Clock in the Dark

Our species’ waking and sleeping cycles–shaped in millions of years of evolution–have been turned upside down within a single century with the advent of electric lighting and airplanes.

PennBlueLight

Penn Researchers Untangle the Biological Effects of Blue Light

Blue light can both set the mood and set in motion important biological responses. Researchers at the University of Pennsylvania’s School of Medicine and School of Arts and Sciences have teased apart the separate biological responses of the human eye to blue light, revealing an unexpected contest for control.